Company: Atara Biotherapeutics
Job title: VP, Head of Global Market Access
Manny Duenas is the Head of Global Market Access at Atara Biotherapeutics, a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. Atara is developing tab-cel® for patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder, an aggressive, often deadly disease.
Prior to joining Atara, Manny built the Global Market Access function at Gilead Sciences, where he led access and pricing for Gilead’s emergence into oncology as well as its flagship HIV franchise. He has also worked across commercial roles for AVEO Oncology, Genentech, and Biogen Idec. Manny began his career as a founding consultant with PriceSpective, a global access consultancy later purchased by ICON. He has spearheaded the commercialization of five on-market therapies and consulted across dozens.
Manny received his MBA from the MIT Sloan School of Management and was previously a J. William Fulbright Fellow to Germany.